[HTML][HTML] Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
L Zhong, Y Li, L Xiong, W Wang, M Wu… - Signal transduction and …, 2021 - nature.com
Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs,
targeted therapeutic drugs have become mainstream cancer treatments. Since the first …
targeted therapeutic drugs have become mainstream cancer treatments. Since the first …
Kinase drug discovery 20 years after imatinib: progress and future directions
Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or
mutations in their genes, cause cancer and other diseases. Here, we review the remarkable …
mutations in their genes, cause cancer and other diseases. Here, we review the remarkable …
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …
[HTML][HTML] Role of matrix metalloproteinases in angiogenesis and cancer
S Quintero-Fabián, R Arreola… - Frontiers in …, 2019 - frontiersin.org
During angiogenesis, new vessels emerge from existing endothelial lined vessels to
promote the degradation of the vascular basement membrane and remodel the extracellular …
promote the degradation of the vascular basement membrane and remodel the extracellular …
Role of the CCL2‐CCR2 signalling axis in cancer: mechanisms and therapeutic targeting
M Xu, Y Wang, R Xia, Y Wei, X Wei - Cell proliferation, 2021 - Wiley Online Library
The chemokine ligand CCL2 and its receptor CCR2 are implicated in the initiation and
progression of various cancers. CCL2 can activate tumour cell growth and proliferation …
progression of various cancers. CCL2 can activate tumour cell growth and proliferation …
[HTML][HTML] Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade
C Genova, C Dellepiane, P Carrega… - Frontiers in …, 2022 - frontiersin.org
In the last decade, the treatment of non-small cell lung cancer (NSCLC) has been
revolutionized by the introduction of immune checkpoint inhibitors (ICI) directed against …
revolutionized by the introduction of immune checkpoint inhibitors (ICI) directed against …
[HTML][HTML] Molecular bases of VEGFR-2-mediated physiological function and pathological role
X Wang, AM Bove, G Simone, B Ma - Frontiers in Cell and …, 2020 - frontiersin.org
The vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) play crucial
roles in vasculogenesis and angiogenesis. Angiogenesis is an important mechanism in …
roles in vasculogenesis and angiogenesis. Angiogenesis is an important mechanism in …
Tumor angiogenesis and anti-angiogenic strategies for cancer treatment
Angiogenesis is the process through which novel blood vessels are formed from pre-existing
ones and it is involved in both physiological and pathological processes of the body …
ones and it is involved in both physiological and pathological processes of the body …
[PDF][PDF] Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis
Vascular endothelial growth factor (VEGF) represents a growth factor with important pro-
angiogenic activity, having a mitogenic and an anti-apoptotic effect on endothelial cells …
angiogenic activity, having a mitogenic and an anti-apoptotic effect on endothelial cells …
[HTML][HTML] Ketogenic diet in the treatment of cancer–where do we stand?
DD Weber, S Aminzadeh-Gohari, J Tulipan… - Molecular …, 2020 - Elsevier
Background Cancer is one of the greatest public health challenges worldwide, and we still
lack complementary approaches to significantly enhance the efficacy of standard anticancer …
lack complementary approaches to significantly enhance the efficacy of standard anticancer …